-
There Is A Warning About Increased Risk Of Lower Limb Amputations For Invokana And Invokamet (Only)
Going Into 2019 The Issue Of These Amputations Being An SGLT2 Inhibitors Drug Class Side Effect Remains Open To Debate (Posted by Tom Lamb at DrugInjuryWatch.com) A year-and-a-half ago we wrote this…
-
Breast Implants Recall: Allergan Textured Products In Europe Removed From Market December 2018
Regulatory Action In France Due To Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Cases (Posted by Tom Lamb at DrugInjuryWatch.com) There have been more than 600 cases of Breast Implant-Associated Anaplastic Large…
-
Diabetes Drugs In DPP-4 Inhibitor Class Associated With Almost Two-Times Increased Risk Of Cholangiocarcinoma
Medical Researchers Finding This Rare But Highly Fatal Cancer Call For More Investigation Into New Possible Drug Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) A recent medical study shows that the…
-
Lemtrada: Warnings About Strokes And Arterial Dissections / Blood Vessel Lining Damage Added To Drug Label
Symptoms Developed Within Just One Day Of Lemtrada Injections, And Can Lead To Patient Death Or Permanent Disability Says FDA (Posted by Tom Lamb at DrugInjuryWatch.com) In late November 2018 this FDA…
-
Farxiga And Jardiance Are Associated With Twofold Increased Risk For Lower Limb Amputations
November 2018: The BMJ Medical Journal Publishes New SGLT2 Diabetes Drug Observational Study (Posted by Tom Lamb at DrugInjuryWatch.com) Diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) inhibitors class are associated with…
-
CoaguChek XS PT Test Strips: Roche Devices For Blood Thinner INR Measurement – Urgent FDA Recall November 2018
More Than 1 Million Packages Of Defective Devices Used To Check INR For Warfarin May Cause Serious Injuries Or Death (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2018 Roche Diagnostics issued…
